Celsion Corp

Find Ratings Reports
CLSN : NASDAQ : Health Care
$0.286 -0.012 | -4.0%
Today's Range: 0.2812 - 0.2949
Avg. Daily Volume: 2890800.0
03/30/17 - 12:46 PM ET

Financial Analysis


CELSION CORP's gross profit margin for the fourth quarter of its fiscal year 2016 has significantly increased when compared to the same period a year ago. Sales have remained unchanged, but net income increased.

At the same time, stockholders' equity ("net worth") has significantly decreased by 67.01% from the same quarter last year.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY16 Q4 FY15
Net Sales ($mil)0.130.13
EBITDA ($mil)0.0-4.84
EBIT ($mil)-5.13-4.95
Net Income ($mil)-5.4-5.51


Balance Sheet Q4 FY16 Q4 FY15
Cash & Equiv. ($mil)4.3120.07
Total Assets ($mil)30.8549.06
Total Debt ($mil)2.566.45
Equity ($mil)6.7320.39


Profitability Q4 FY16 Q4 FY15
Gross Profit Margin-4107.2-3875.2
EBITDA Margin0.0-3875.2
Operating Margin-4107.2-3957.6
Sales Turnover0.020.01
Return on Assets-71.49-45.78
Return on Equity-327.94-110.17
Debt Q4 FY16 Q4 FY15
Current Ratio0.542.17
Debt/Capital0.280.24
Interest Expense0.00.28
Interest Coverage0.0-17.54


Share Data Q4 FY16 Q4 FY15
Shares outstanding (mil)26.0623.32
Div / share0.00.0
EPS-0.19-0.24
Book value / share0.260.87
Institutional Own % n/a n/a
Avg Daily Volume2745848.0171343.0

Valuation


SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 1.05 indicates a significant discount versus the S&P 500 average of 2.93 and a significant discount versus the industry average of 11.85. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, CELSION CORP proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
CLSN NM Peers 38.87   CLSN NM Peers 22.28

Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.

CLSN's P/E is negative making this valuation measure meaningless.

 

Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

CLSN's P/CF is negative making the measure meaningless.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
CLSN NM Peers 58.77   CLSN NA Peers 0.49

Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.

CLSN's ratio is negative making this valuation measure meaningless.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
CLSN 1.05 Peers 11.85   CLSN 19.05 Peers 165.61

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

CLSN is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, CLSN is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
CLSN 14.07 Peers 256.31   CLSN 0.00 Peers 609.16

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

CLSN is trading at a significant discount to its industry on this measurement.

 

Neutral. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

The growth rate for CLSN is not available.

 

 

Latest Stock Upgrades/Downgrades